Subsequent univariate and multivariate COX regression analysis highlighted POLD1 and SLC26A6 as potential prognostic indicators for PRAD patients, with POLD1 standing out (Fig. 9F-G). Here, SLC26A6 is linked to prostate adenocarcinoma.